Could a Cannabis-Like drug tame lupus pain?

NCT ID NCT03093402

First seen May 07, 2026 ยท Last updated May 07, 2026

Summary

This study tested a new drug called JBT-101 (lenabasum) in 109 adults with lupus who had joint pain. The drug aims to calm the immune system without shutting it down. Participants took either the drug or a placebo for 84 days, and researchers tracked changes in their daily pain levels. The goal was to see if JBT-101 could safely reduce pain and improve quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bronx-Lebanon Hospital Center: Division of Rheumatology

    The Bronx, New York, 10457, United States

  • Columbia University Medical Center: Department of Medicine, Division of Rheumatology

    New York, New York, 10032, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • Emory University: Division of Rheumatology

    Atlanta, Georgia, 30322, United States

  • Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases

    Manhasset, New York, 11030, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • MetroHealth Medical Center

    Cleveland, Ohio, 44109, United States

  • New York University Langone Medical Center: Department of Medicine, Division of Rheumatology

    New York, New York, 10016, United States

  • Penn State MS Hershey Medical Center

    Hershey, Pennsylvania, 17033, United States

  • Temple University

    Philadelphia, Pennsylvania, 19140, United States

  • UCLA Medical Center: Division of Rheumatology

    Los Angeles, California, 90095, United States

  • University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology

    La Jolla, California, 92093, United States

  • University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center

    San Francisco, California, 94143, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology

    Pittsburgh, Pennsylvania, 15217, United States

  • Yale University

    New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.